Drug Information Association Logo
Corporate Tagline

#50: Understanding and Navigating the Regulatory System in China

Jun 23 2013 9:00AM - Jun 23 2013 5:00PM | Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA

« Back to Listing

Learning Objectives 

At the conclusion of this tutorial, participants should be able to:

  • Describe the regulatory system in China, including the agencies and institutions and their roles and responsibilities in the regulatory processes for clinical trial and registration approval, as well as safety reporting
  • Explain the history and the recent changes in the regulatory system in China and future perspectives
  • Describe the regulatory pathways and strategic considerations for successful clinical trial and marketing applications in China
  • Discuss how to navigate the regulatory system in China for clinical trial approval and product registration.

Instructor(s) 

Previous Next

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

Participants with Disabilities:
Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.

« Back to Listing Back To Top